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Synthesis and kinetic resolution of
N-Boc-2-arylpiperidines†
Edward J. Cochrane,a Daniele Leonori,a Lorraine A. Hassallb and Iain Coldham*a
The chiral base n-BuLi/()-sparteine or n-BuLi/(+)-sparteine surro-
gate promotes kinetic resolution of N-Boc-2-arylpiperidines by
asymmetric deprotonation. The enantioenriched starting material
was recovered with yields 39–48% and ers up to 97 : 3. On lithiation
then electrophilic quench, 2,2-disubstituted piperidines were
obtained with excellent yields and enantioselectivities.
Piperidines substituted in the 2-position with at least one aryl group
are a class of molecules often possessing high biological activities
and are therefore of interest to synthetic organic, medicinal and
process chemists.1 For example, piperidine 1 is a poly ADP ribose
polymerase inhibitor (Fig. 1).2 Piperidine 2 is a lead compound for
orally active NK1 antagonists.
3 Piperidine 2 was synthesised by Xiao
and co-workers as a mixture of diastereomers via the THF-mediated
lithiation-substitution of ()-N-Boc-2-phenylpiperidine.3a The need
for a stereoselective synthesis is exemplified by the B50-fold
diﬀerence in activity between the HCl salt of the (R,R) and the
(R,S) diastereomers (IC50 0.3 nM and415 nM, respectively).
4
A general approach to the asymmetric synthesis of 2,2-
disubstituted piperidines continues to pose a problem for synthetic
chemists. Building on their expertise of lithiated nitrogen-containing
heterocycles, Coldham andO’Brien and co-workers reported that the
Boc group in N-Boc-2-phenylpiperidine rotates rapidly, even at
78 1C, to allow high yields of lithiation at the benzylic position
and that the organolithium is configurationally stable at low tem-
perature.5 This led to the synthesis of enantiomerically enriched
2-alkyl-2-phenylpiperidines, such as piperidine 4a, using enantio-
merically enriched N-Boc-2-phenylpiperidine 3a (Scheme 1).
The enantioenriched N-Boc-2-phenylpiperidine (S)-3a was
obtained by an asymmetric reduction of the corresponding
cyclic imine.5a An alternative approach is by Negishi reaction
using the chiral organozinc species formed either from the
2-tributylstannane, itself formed by dynamic resolution of 2-lithiated
N-Boc-piperidine,6 or directly by ‘catalytic dynamic resolution’,7
although the latter method was unsuccessful in our hands. We
therefore sought a simpler method and wondered if racemic N-Boc-
2-arylpiperidines were amenable to kinetic resolution. There is
growing interest in the kinetic resolution of amines, mostly by
N-acylation.8 In contrast, the kinetic resolution of amines by depro-
tonation has received very little study.9 The closest example is that
from Beak and co-workers, who showed that the chiral base n-BuLi/
()-sparteine can eﬀect a kinetic resolution of an acyclic N-Boc-a-
methylbenzylamine, albeit with fairly low selectivity (er up to 81 :19
for 12% yield of recovered starting material).9a In this paper, we
report that N-Boc-2-arylpiperidines are excellent substrates for highly
selective kinetic resolution by asymmetric deprotonation.
Racemic N-Boc-2-phenylpiperidine and related 2-aryl or 2-hetero-
aryl derivatives can be prepared by several diﬀerent methods.10
We selected to extend the method used for racemic 3a,5a for the
preparation of a variety of N-Boc-2-arylpiperidines (Scheme 2).
Addition of the aryllithium, obtained by bromine–lithium exchange,
to 5-bromovaleronitrile, followed by reduction of the intermediate
cyclic imine with sodium borohydride and addition of Boc2O gave
Fig. 1 Some biologically active 2-arylpiperidines.
Scheme 1 Lithiation-substitution of piperidine 3a.
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the desired racemic piperidines 3a–g. Reasonable yields for the
three-step procedure were obtained, except with p-MeOC6H4Li
which gave significant amounts of methoxybenzene, perhaps due
to its propensity to abstract a proton alpha to the nitrile. The
corresponding organomagnesium reagent was no more successful.
For the kinetic resolution of these substrates, we initially
focused on developing conditions using the substrate 3a. A mixture
of 0.55 equiv. of n-BuLi and ()-sparteine (pre-mixed for 5 min) in
PhMe was used for the lithiation of N-Boc-2-phenylpiperidine 3a
(Scheme 3). After 5 min, addition of iodomethane gave the product
4a in 30% yield with a promising er (79 : 21). With the electrophile
ethyl chloroformate, both the yield of the product 5a and the er
were improved. By changing the solvent to Et2O, a similar er
(87 : 13) of 5a was obtained but in reduced yield (see ESI† for yield
and er of recovered 3a). The er was determined by chiral stationary
phase (CSP) HPLC and the optical rotation of 4a (see ESI†) matched
that reported for the (S) enantiomer.5a These data predict, as
expected based on the lithiation of N-Boc-piperidine,11 that the
enantiomer (S)-3a is preferentially lithiated by n-BuLi/()-sparteine.
As an alternative, we investigated a diﬀerent method of addi-
tion, whereby n-BuLi and ()-sparteine were not premixed. n-BuLi
was added to a solution containing the piperidine 3a and ()-spar-
teine in PhMe. After diﬀerent time periods the electrophile
EtOCOCl was added (Table 1). A marked improvement in the er
of the product 5a was obtained, and this was associated with a
significant decrease in yield. By increasing the reaction time to 3 h,
it was possible to obtain the product 5 with er 92 :8 and a yield of
42% (entry 5).
To investigate the diﬀerences in reaction times for these
methods, we performed in situ IR spectroscopy to monitor the
stretching frequency of the carbonyl group (Fig. 2). When using
pre-mixed n-BuLi/()-sparteine (Fig. 2a), partial lithiation
occurs over about 15 min, as judged by the steady but partial
loss of ncQo 1691 cm1 (CQO stretch for 3a) and formation of a
new peak at 1640 cm1 (assigned to ncQo in the lithiated
intermediate). However, without pre-mixing, the lithiation
required several hours (Fig. 2b). The method chosen clearly
impacts on the selectivity, with the slower lithiation allowing a
Scheme 2 Synthesis of ()-N-Boc-2-arylpiperidines 3a–g.
Scheme 3 Initial study of the kinetic resolution with pre-mixed n-BuLi/
()-sparteine.
Table 1 Kinetic resolution to give 5a with n-BuLi and ()-sparteinea
Entry Time (min) Yieldb 5a (%) erc 5a
1 10 16 95 : 5
2 30 27 95 : 5
3 60 33 93 : 7
4 120 36 93 : 7
5 180 42 92 : 8
a For yield and er of recovered 3a, see ESI. b Yield of isolated product.
c Determined by CSP HPLC.
Fig. 2 In situ IR plots of the lithiation of 3a with n-BuLi/()-sparteine at
78 1C in PhMe with time in h:min:s. (a) ncQo 3a (1691 cm1), pre-mixed
n-BuLi/()-sparteine added at time 16 min, ncQo lithiated 3a (1640 cm1);
(b) ncQo 3a (1691 cm
1) and ()-sparteine then n-BuLi added at time
16 min, ncQo lithiated 3a (1640 cm1).
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more selective reaction. The faster reaction occurs with the pre-
mixed n-BuLi/()-sparteine complex that will have a higher
concentration of the dimeric aggregation state.12
With optimised conditions in-hand, we studied the use of other
electrophiles but these gave lower yields and ers (37% yield, er
82 :18 using allyl bromide; 24% yield, er 74 :26 using MeI). The
lower selectivities may be due to partial racemisation of the
lithiated intermediate prior to slower electrophilic quench.
Due to the variation in er dependent on the choice of electro-
phile, we decided to focus on obtaining a good yield and er for the
recovered starting material. This was investigated by varying the
number of equivalents of the chiral base (Table 2). The best
conditions that we found used 0.7 equiv. of n-BuLi and ()-spar-
teine and gave an excellent yield and er of recovered 3a (entry 2).
A yield of 45% with er 96 : 4 (R :S) corresponds to a relative rate of
reaction for the two enantiomers krelB 22.
13
The kinetic resolution was then tested with the diﬀerent
2-arylpiperidines that were prepared as shown in Scheme 2. We
were pleased to find that high levels of selectivity could be achieved
withmany of these compounds (Scheme 4). The yields and er values
of the recovered starting materials are given in Scheme 4 for the
diﬀerent aromatic derivatives and it was found that both electron-
poor (p-chloro 3b, p-fluoro 3c) and electron-rich (p-methoxy 3e)
substituents are tolerated in the kinetic resolution. However, some
loss in selectivity occurs with the 3,5-bis-trifluoromethyl 3f and
2-pyridyl 3g derivatives. This may be due to a faster and therefore
less selective lithiation with these more acidic substrates.
In addition, we have demonstrated that the other enantiomer of
the 2-arylpiperidine can be formed by changing the chiral ligand to
O’Brien’s (+)-sparteine surrogate.14 This resulted in the formation
of (S)-3a (41% yield, er 91 : 9) and (S)-3b (42% yield, er 84 : 16).
This methodology is reliant on using ethyl chloroformate as a
sacrificial electrophile, consuming the undesired enantiomer. The
kinetic resolution was tested with Me3SnCl as the electrophile
(Scheme 5). This could enable a subsequent tin–lithium exchange
to recover the starting material after proton quench. The kinetic
resolution performed well using this electrophile to give the recov-
ered piperidine 3a in 42% yield and er 94 :6. The er of the stannane
6a was not determined but this product was treated with n-BuLi in
THF followed by addition of acetic acid. When this reaction was
conducted at 78 1C, the piperidine (S)-3a was isolated with er
82 :18, suggesting that tin–lithium exchange and protonation
occurs with retention of configuration. However, when the exchange
and protonation was conducted at room temperature, racemic 3a
was recovered in high yield. Therefore this approach allows recy-
cling of the undesired product to allow a further kinetic resolution.
Finally, we have performed THF-mediated lithiation then sub-
stitution on the enantioenriched recovered starting materials to
show that these are amenable to the formation of 2,2-disubstituted
piperidines without loss of enantioselectivity.5,15 Treatment of the
piperidine (R)-3b (er 96 :4) with n-BuLi followed by MeI, EtOCOCl
or allyl bromide gave the products 4b, 5b, and 7b with good yields
Table 2 Kinetic resolution of 3a with n-BuLi and ()-sparteine
Entry
Equiv. n-BuLi
and ()-sp
Yielda (%)
and erb 3a (%)
Yield (%)
and erb 5a (%)
1 0.55 50 (77 : 23) 42 (92 : 8)
2 0.7 45 (96 : 4) 51 (86 : 14)
3 0.8 31 (92 : 8) 56 (77 : 23)
4 1.0 13 (98 : 2) 74 (57 : 43)
a Yield of isolated starting material. b Determined by CSP HPLC.
Scheme 4 Kinetic resolution of various N-Boc-2-arylpiperidines.
Scheme 5 Kinetic resolution of N-Boc-2-phenylpiperidine with Me3SnCl
quench.
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and with no loss of enantioselectivity (Scheme 6). Similarly, piperi-
dines (R)-3c (er 94 :6) and (R)-3d (er 97 : 3) gave the products 4c, 5c,
and 4d with good yields and very little reduction in er. Based on
related chemistry using piperidine 3a,5 we assume that the absolute
configuration of these products is as shown, in which lithiation and
electrophilic quench occur with retention of configuration.
The chiral base n-BuLi with ()-sparteine or the (+)-sparteine
surrogate is eﬀective for the kinetic resolution of racemic N-Boc-2-
arylpiperidines in PhMe. The recovered starting material can be
isolated with high enantiomer ratios, especially if n-BuLi and the
chiral ligand are not pre-mixed. Use of in situ IR spectroscopy
helped to optimise the conditions for the kinetic resolution. By
using a trialkyltin halide electrophile, the quenched product can be
recycled by tin–lithium exchange and protonation. After kinetic
resolution, the recovered enantioenriched N-Boc-2-arylpiperidines
can be deprotonated with n-BuLi in THF at 78 1C and quenched
with electrophiles without loss of enantiopurity to provide highly
enantioselective syntheses of 2,2-disubstituted piperidine products.
We thank the EPSRC, the University of Sheﬃeld and Astra-
Zeneca for funding.
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